BB Biotech AG logo

BB Biotech AG (BION)

Market Closed
10 Aug, 15:20
SIX SIX
53. 20
CHF
+1.1
+2.1113%
CHF
2.49B Market Cap
9% Div Yield
74,308 Volume
52.1 CHF
Previous Close
Add Transaction
Day Range
51.9 53.2
Year Range
30.75 53.3
Want to track BION and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

BB Biotech AG (BION) Statistics

Valuation metrics

Market Cap 2.49B
Enterprise value 2.67B
Trailing P/E (ttm) 2.13
Forward P/E -69.17
PEG ratio 0
Price/Sales (ttm) 19.68
Price/Book (mrq) 0.93
Enterprise Value/Revenue 18.28
Enterprise Value/EBITDA 1.98

Overview

Shares outstanding 55.15M
Float -
Shares short -
% Held by insiders 0%
% Held by institutions 0.18%
Average volume (10 days) 108.89K
Average volume (90 days) 80.13K

Price summary

52-Week low 30.75
52-Week high 53.3
Beta 0.63
50-Day moving average 49.89
200-Day moving average 46.41

Dividends and splits

Forward annual dividend rate 9
Forward annual dividend yield 0.1982%
Trailing annual dividend rate 2.25
Trailing annual dividend yield 0.0432%
5-Year annual dividend yield 5.65%
Payout ratio 0.09
Dividend Date 25 Mar 2026
Ex-Dividend Date 23 Mar 2026
Last split factor 5:1
Last split Date 29 Mar 2016

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 9.24%
Operating margin 9.25%

Operational effectiveness

Return on assets 0.44%
Return on equity 0.5%

Income Statement

Revenue (ttm) 616.88M
Revenue per share (ttm) 2.65
Quarterly revenue growth (yoy) 13.11%
Gross profit (ttm) 616.88M
EBITDA -
Net income to common (ttm) 797.69M
Diluted EPS (ttm) 24.46
Quarterly earnings growth (yoy) -1.28%

Balance Sheet

Total cash (mrq) 2.64B
Total cash per share (mrq) 55.78
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 336.03%
Book value per share (mrq) 55.93

Cash Flow

Cash flow statement 393.7M
Levered free cash flow (LFCF) 2.24B